Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly
Ruth Peters, Andrew Booth, Jean Peters
Journal of Hypertension (2014) Vol. 32, Iss. 10, pp. 1945-1958
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta‐analyses
Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, et al.
Alzheimer s & Dementia (2016) Vol. 13, Iss. 4, pp. 406-418
Open Access | Times Cited: 249
Investigation of antihypertensive class, dementia, and cognitive decline
Ruth Peters, Sevil Yaşar, Craig S. Anderson, et al.
Neurology (2019) Vol. 94, Iss. 3
Open Access | Times Cited: 119
Risk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study
Nisha Nigil Haroon, Peter C. Austin, Baiju R. Shah, et al.
Diabetes Care (2015) Vol. 38, Iss. 10, pp. 1868-1875
Open Access | Times Cited: 111
Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease
Pu Wang, Zhan‐You Wang
Ageing Research Reviews (2016) Vol. 35, pp. 265-290
Closed Access | Times Cited: 110
Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer’s Disease? A Systematic Review and Meta-Analysis
Susanna C. Larsson, Hugh S. Markus
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. 2, pp. 657-668
Open Access | Times Cited: 85
Diuretic antihypertensive drugs and incident dementia risk
Phillip J. Tully, Olivier Hanon, Suzanne Cosh, et al.
Journal of Hypertension (2016) Vol. 34, Iss. 6, pp. 1027-1035
Closed Access | Times Cited: 74
Lower dementia risk with different classes of antihypertensive medication in older patients
Tessa van Middelaar, Lonneke A. van Vught, Eric P. Moll van Charante, et al.
Journal of Hypertension (2017) Vol. 35, Iss. 10, pp. 2095-2101
Closed Access | Times Cited: 50
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
Emma Cunningham, Stephen Todd, Peter Passmore, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 36
Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies
Salman Hussain, Ambrish Singh, Syed Obaidur Rahman, et al.
Neuroscience Letters (2018) Vol. 671, pp. 120-127
Closed Access | Times Cited: 46
Benefits and risks of antihypertensive medications in the elderly
Debra A. Butt, Paula Harvey
Journal of Internal Medicine (2015) Vol. 278, Iss. 6, pp. 599-626
Open Access | Times Cited: 41
Calcium-Channel Blockers and Dementia Risk in Older Adults – National Health Insurance Service – Senior Cohort (2002–2013) –
Deri Hwang, Sun Young Kim, Hangseok Choi, et al.
Circulation Journal (2016) Vol. 80, Iss. 11, pp. 2336-2342
Open Access | Times Cited: 39
Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review
Wei Yang, Hongyu Luo, Yixin Ma, et al.
Aging and Disease (2021) Vol. 12, Iss. 3, pp. 841-841
Open Access | Times Cited: 28
Effects of Hypertension on Alzheimer’s Disease and Related Disorders
Joseph E. Malone, Mohamed Elkasaby, Alan J. Lerner
Current Hypertension Reports (2022) Vol. 24, Iss. 12, pp. 615-625
Closed Access | Times Cited: 20
Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
Mark A. Lovell, Erin L. Abner, Richard J. Kryscio, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-9
Open Access | Times Cited: 39
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
Hai-Long Dai, Wei-yuan Hu, Li-hong Jiang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 36
Dementia risk with antihypertensive use and blood pressure variability
Phillip J. Tully, Jean‐François Dartigues, Stéphanie Debette, et al.
Neurology (2016) Vol. 87, Iss. 6, pp. 601-608
Closed Access | Times Cited: 36
A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients
Chia‐Liang Wu, Shu‐Hui Wen
Medicine (2016) Vol. 95, Iss. 32, pp. e4593-e4593
Open Access | Times Cited: 35
Joining forces to prevent dementia: The International Research Network On Dementia Prevention (IRNDP)
Kaarin J. Anstey, Ruth Peters, Linda Clare, et al.
International Psychogeriatrics (2017) Vol. 29, Iss. 11, pp. 1757-1760
Open Access | Times Cited: 33
Comparable cerebral cortex activity and gait performance in elderly hypertensive and healthy individuals during dual‐task walking: A fNIRS study
Qiuru Yao, Ling Chen, Hang Qu, et al.
Brain and Behavior (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 3
Antihypertensive drug use and risk of cognitive decline in the very old
Ruth Peters, Joanna Collerton, Antoneta Granic, et al.
Journal of Hypertension (2015) Vol. 33, Iss. 10, pp. 2156-2164
Closed Access | Times Cited: 25
Effect of SSRI and calcium channel blockers on depression symptoms and cognitive function in elderly persons treated for hypertension: three city cohort study
Phillip J. Tully, Ruth Peters, Karine Pérès, et al.
International Psychogeriatrics (2018) Vol. 30, Iss. 9, pp. 1345-1354
Closed Access | Times Cited: 24
Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension
Laura Peeters, M.P. Kester, Lida Feyz, et al.
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 4, pp. 287-297
Closed Access | Times Cited: 22
Amlodipine treatment of hypertension associates with a decreased dementia risk
Leonid Feldman, Shlomo Vinker, Shai Efrati, et al.
Clinical and Experimental Hypertension (2016) Vol. 38, Iss. 6, pp. 545-549
Closed Access | Times Cited: 21
Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review
Jean Peters, Andrew Booth, Ruth Peters
Therapeutic Advances in Chronic Disease (2015) Vol. 6, Iss. 4, pp. 160-169
Open Access | Times Cited: 20
Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study
Irena Kalar, Hong Xu, Juraj Sečník, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 4, pp. 508-522
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top